Free-cash-flow proxy increased 45.0%
Free-cash-flow proxy changed +45.0% from the comparable as-filed period.
$39.2M→$56.9M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TTAN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 43.8%
Operating cash flow changed +43.8% from the comparable as-filed period.
$40.3M→$58.0M3 prior comparisons
Operating margin moved 495 bp higher
Operating margin changed +495 basis points from the comparable as-filed period.
-14.36%→-9.41%2 prior comparisons
Research & development increased 37.7%
Research & development changed +37.7% from the comparable as-filed period.
$73.1M→$100.6M2 prior comparisons
Revenue increased 20.9%
Revenue changed +20.9% from the comparable as-filed period.
$242.1M→$292.8M2 prior comparisons
Trade receivables increased 34.7%
Trade receivables changed +34.7% from the comparable as-filed period.
$51.9M→$69.9M3 prior comparisons
Operating income increased 20.8%
Operating income changed +20.8% from the comparable as-filed period.
-$34.8M→-$27.6M2 prior comparisons
Free-cash-flow proxy increased 86.4%
Free-cash-flow proxy changed +86.4% from the comparable as-filed period.
-$15.9M→-$2.2M2 prior comparisons
Gross margin moved 329 bp higher
Gross margin changed +329 basis points from the comparable as-filed period.
68.80%→72.09%2 prior comparisons
Operating income increased 48.0%
Operating income changed +48.0% from the comparable as-filed period.
-$49.5M→-$25.8M2 prior comparisons
Operating margin moved 1338 bp higher
Operating margin changed +1338 basis points from the comparable as-filed period.
-22.97%→-9.58%2 prior comparisons
Operating cash flow increased 89.3%
Operating cash flow changed +89.3% from the comparable as-filed period.
-$14.6M→-$1.6M2 prior comparisons
Net income increased 50.8%
Net income changed +50.8% from the comparable as-filed period.
-$46.4M→-$22.8M2 prior comparisons
Revenue increased 24.6%
Revenue changed +24.6% from the comparable as-filed period.
$215.7M→$268.8M2 prior comparisons
Gross profit increased 30.6%
Gross profit changed +30.6% from the comparable as-filed period.
$148.4M→$193.8M2 prior comparisons
Research & development increased 27.3%
Research & development changed +27.3% from the comparable as-filed period.
$69.1M→$88.0M2 prior comparisons
Trade receivables increased 37.7%
Trade receivables changed +37.7% from the comparable as-filed period.
$46.0M→$63.4M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.